Radiologists behind increase in percutaneous thoracic biopsies, resulting in fewer invasive biopsies.
Radiologists are increasingly responsible for thoracic diagnosis as they perform more thoracic biopsies than ever before, according to a study published in the Journal of the American College of Radiology. Researchers from Thomas Jefferson University Hospital and Jefferson Medical College, in Philadelphia, Penn., sought to examine the utilization rate of various types of thoracic biopsies within the Medicare population. Primary claims submitted percutaneous thoracic biopsy, bronchoscopic thoracic biopsy, and surgical thoracic biopsy between 1998 and 2010 were reviewed. There were 176,125 total thoracic biopsies in 1998 and a drop to 167,911 (-4.7 percent) in 2010. There was a decrease from 5.47 per 1,000 in 1998 to 4.76 per 1,000 (−13.0%) in 2010 for all thoracic biopsies. There was an increase in percutaneous biopsy of 3.6 percent, decrease in surgical biopsy by 29.0 percent, and decrease in bronchoscopic biopsy by 19.6 percent. “In 2010, radiologists performed 96.4 percent (58,679) of all percutaneous biopsies,” the authors wrote. “Radiologists' thoracic biopsy market share increased from 26.2 percent (46,084 of 176,125) in 1998 to 35.0 percent (58,700 of 167,911) in 2010 (+33.6%).” The researchers concluded that radiologists are responsible for the increasing role of thoracic diagnosis, which may be the result of changing trends to less invasive procedures, differing patterns of reimbursement, and increased availability of percutaneous biopsy.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.